[Experimental studies on the elimination and neurotoxicity of a new water soluble contrast medium for lumbosacral myelography].
D000272:Adipates / Q000009:adverse effects / Q000378:metabolism; D002552:Cerebral Ventricles / Q000378:metabolism; D003287:Contrast Media / Q000009:adverse effects / Q000378:metabolism* / Q000652:urine; D006207:Half-Life; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007455:Iodine / Q000009:adverse effects / Q000378:metabolism; D007457:Iodine Radioisotopes; D008161:Lumbosacral Region; D009192:Myelography; D009422:Nervous System Diseases / Q000139:chemically induced*; D010795:Phthalic Acids / Q000009:adverse effects / Q000378:metabolism*; D013012:Sorbitol / Q000009:adverse effects / Q000378:metabolism*; D013115:Spinal Canal / Q000378:metabolism; D013961:Thyroid Gland / Q000378:metabolism
D000272:Adipates; D003287:Contrast Media; D007457:Iodine Radioisotopes; D010795:Phthalic Acids; D013012:Sorbitol; D007455:Iodine
Experimentelle Untersuchungen über die Elimination und Neurotoxizität eines neuen, wasserlöslichen Kontrastmittels zur lumbosakralen Myelographie.